Plandai Biotechnology is a company that produces a variety of green tea extracts, which are designed to increase bioavailability. Green tea has shown many health benefits in the past. To find out what makes Plandai different, see this review below.
What Is Plandaí Biotechnology?
Plandai is a company located with their head office in London, England, although the facility where they grow the products for their supplements seems to be in the South Africa. They also have a headquarters in the United States making them an international organization.
While the company is currently interested in getting involved in the cannabis extract industry, it is patiently waiting for government approval in order to get access to full scale clinical trials.
These will start with animals and then move onto humans. As it stands right now, however, Plandai is only cultivating legal plant extracts, and doing so under these same strict guidelines of using scientific data to back up their extract products.
Plandaí Biotechnology Products
Plandaí Biotechnology sells its products under the name Phytophare, and as stated above primarily relies on green tea extracts. They have published their data, to help those who may be interested in supplements but require empirical evidence to defend it.
Their main products are all developed around green tea extracts, and include several compounds known as catechins. The theory goes that the catechins like EGCG, GCG, and ECG, can help to slow the aging look of skin, when applied, but also due to their antioxidant nature, have a series of health benefits.
What makes this company different is their interest in basing their work off of evidence they actually have. Rather than just noting that their product works for increasing skin hydration, decreasing roughness and reducing scaliness, they also note effects that were not empirically demonstrated such as skin elasticity.
In terms of other people’s research there is a lot of evidence to suggest that green tea catechins can help with weight loss, and fat oxidation, two things that catechin is looking to examine right now.
Antioxidants are also very useful for helping to avert other health problems. If their research on an increase in bioavailability for the skincare product is true for their supplement, then this will be a big boon for people looking for healthy supplements with a proven efficacy.
For those interested in the news on Phytophare becoming involved in the cannabis industry, Phytophare is remaining hesitant until they receive research approval from the South African government. Plandai would attempt to apply their current method of extraction to cannabis, extracting all the cannabinoids except THC.
If the technique works it could create an alternative for those who need access to medical cannabis but do not enjoy the psychoactive effects. Due to the company’s interest in controlling the process from the growth of the plant to extraction, this may take longer, and will depend entirely on the South African government.
Plandaí Biotechnology Pricing
This company is currently just getting off its feet due to the amount of time they have spent in research and development of their product. For those looking for Phytophare®, the company is expected to release its first order sometime in the beginning of this financial quarter to famous supplement company Capital Brands LLC, which distributes NutriBullet among other supplements.
This supplement will only be available first and exclusively for the first while only in the United States.
Should You Use Plandaí Biotechnology Products?
These products are designed for both skeptical consumer, and those who are more innovative in their purchases of supplements. There are few supplement companies that invest research money into actively demonstrating that their product works. It is still too early to say whether it will be worth it on the price alone.
However, the company seems to think that it can offer extracts that are both more bioavailable and cheaper using non-genetically modified plants. The supplements from this company seem to be worth giving a test when they enter the United States market in the next couple of months.
